Search

Your search keyword '"Paul L. Richardson"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Paul L. Richardson" Remove constraint Author: "Paul L. Richardson"
53 results on '"Paul L. Richardson"'

Search Results

1. Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein

2. Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site

3. A chemical biology toolbox to study protein methyltransferases and epigenetic signaling

4. Supplementary Table S4 from Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

5. Wilsbacher et. al. supplement from Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

7. Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis

8. A chemical biology toolbox to study protein methyltransferases and epigenetic signaling

9. NRF2 activator A-1396076 ameliorates inflammation in autoimmune disease models by inhibiting antigen dependent T cell activation

10. Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

11. SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding

12. Development of inverse electron demand Diels–Alder ligation and TR-FRET assays for the determination of ligand–protein target occupancy in live cells

13. Controlling cellular distribution of drugs with permeability modifying moieties

14. Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective

15. A Chemical Biology Toolbox for the Study of Protein Methyltransferases and Epigenetic Signaling

16. Cell-Surface Receptor-Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors

17. Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation

18. SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)

19. 677 Discovery and characterization of a small molecule IL-36γ antagonist as a novel approach to treat plaque psoriasis

20. Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

21. Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavage

22. Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

23. Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry

24. Discovery, Identification, and Characterization of Candidate Pharmacodynamic Markers of Methionine Aminopeptidase-2 Inhibition

25. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease

26. Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-R S

27. Glycan-Mediated, Ligand-Controlled Click Chemistry for Drug-Target Identification

28. Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform

29. Interactions of Two Monoclonal Antibodies with BNP: High Resolution Epitope Mapping Using Fluorescence Correlation Spectroscopy

30. High-level bacterial expression and purification of human SirT2 protein for NMR studies

31. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction

32. Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure

33. Investigating the Origin of the Slow-Binding Inhibition of HCV NS3 Serine Protease by a Novel Substrate Based Inhibitor

34. Discovering novel ligands for macromolecules using X-ray crystallographic screening

35. Abstract 3059: Discovery of BET family proteins as cancer targets using phenotypic-based profiling and affinity capture mass spectrometry

36. A uniquely modified RNA: Introduction of a single RNA cleavage agent into the M1 ribozyme

37. Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket

38. Elucidating Compound Selectivity: Integration of Chemoproteomic, Protein Signaling, and Gene Expression Profiles

39. Crystal structure and thermodynamic analysis of diagnostic mAb 106.3 complexed with BNP 5-13 (C10A)

40. Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies

41. Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery

42. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase

43. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A

44. Microarrayed compound screening (microARCS) to identify activators and inhibitors of AMP-activated protein kinase

45. Alpha-keto amides as inhibitors of histone deacetylase

46. Indole amide hydroxamic acids as potent inhibitors of histone deacetylases

48. P2-483: Biophysical characterization of soluble amyloid-β peptide oligomers

50. Microarrayed Compound Screening (μARCS) to Identify Activators and Inhibitors of AMP-Activated Protein Kinase.

Catalog

Books, media, physical & digital resources